Refresh
Gainers Losers Sectors Indices Forex Mutual Funds

BGR Energy Systems Ltd.

Price on BSE   26 Feb,14:58 LIVE
331.30
+10.10
(+3.14%)

© 2026 Rediff.com
  • Volume :
  • 3,001.00
  • Prev Close :
  • 321.20
  • Day's H/L (Rs.) :
  • 332.30 - 322.50
  • 52wk H/L (Rs.) :
  • 490.15 - 69.49
  • Mkt Cap (Rs. Cr) :
  • 357.81
Price on NSE   26 Feb,15:07 LIVE
330.00
+9.60
(+3.00%)

© 2026 Rediff.com
  • Volume :
  • 55,542.00
  • Prev Close :
  • 320.40
  • Day's H/L (Rs.) :
  • 336.00 - 321.05
  • 52wk H/L (Rs.) :
  • 490.80 - 69.05
  • Mkt Cap (Rs. Cr) :
  • 0.00
Report Card - BGR Energy Systems Ltd.
PE Ratios
-2.36
EPS (Rs.)
-135.95
Sales (Rs. Cr)
77.71
Face Value (Rs.)
10
Net Profit Margin(%)
-217.43
Last Bonus
-
Last Dividend(%)
30
Return on Average Equity

News for BGR Energy Systems Ltd.

BGR Energy Systems Q2 Loss Narrows
BGR Energy Systems reports a narrowed loss of Rs 62.54 crore in Q2, driven by increased revenues. Financial performance details inside.
Nov 14, 2025 19:36
BGR Energy Loss: Rs 263 Cr in Q1 FY26
BGR Energy Systems reports a widened net loss of Rs 263.02 crore in Q1 FY26, compared to Rs 117.64 crore last year. Income declines, expenses surge.
Aug 14, 2025 18:22
BGR Energy Systems Q3 Loss Narrows to Rs 336 cr
BGR Energy Systems reported a narrowed consolidated loss of Rs 336.27 crore for the December quarter of FY25, attributed to reduced expenses. Total income decreased to Rs 67.33 crore.
Feb 12, 2025 19:16
BGR Energy Systems Q2 Loss Widens to Rs 193 cr
BGR Energy Systems reported a wider loss of Rs 192.79 crore in Q2 FY24, compared to Rs 104.14 crore in the same period last year. Total income also declined to Rs 87.74 crore.
Nov 13, 2024 19:56
Sebi Fines BGR Energy Rs 9 Lakh for Disclosure Lapses
Sebi has penalized BGR Energy Systems Rs 9 lakh for violating disclosure norms and failing to comply with market regulations. The penalty was imposed after an investigation revealed the company's...
Sep 24, 2024 22:26

More News for BGR Energy Systems Ltd. »

News for Engineering

Alembic Pharma Gets USFDA Nod for Generic Drug
Alembic Pharma receives USFDA approval for generic Lamotrigine tablets, used to treat seizures. ANDA equivalent to GlaxoSmithKline's Lamictal.
Feb 26, 2026 14:51
Acerpure Eyes Emerging Markets After India Success
Acerpure plans to expand to Philippines, Vietnam, Thailand, and Indonesia after success in India. Focus on local manufacturing and investment.
Feb 26, 2026 14:49
Gushwork AI Raises Rs 81 Cr Funding
Gushwork AI secures Rs 81 cr funding led by Susquehanna Asia VC. Plans to invest in AI product development, talent & customer acquisition.
Feb 26, 2026 14:48
India Trade Policy Review at WTO in July 2026
India's 8th Trade Policy Review at WTO will take place in July 2026. Focus on digital customs reforms and TFA implementation.
Feb 26, 2026 14:33
Swiggy & IRCTC: Food on Train Expands to 152 Stations
Swiggy and IRCTC expand 'Food on Train' service to 152 stations across India. Holi special menu & train-friendly dishes launched.
Feb 26, 2026 14:25

More News »

Top News

Alembic Pharma Gets USFDA Nod for Generic Drug
Alembic Pharma receives USFDA approval for generic Lamotrigine tablets, used to treat seizures. ANDA equivalent to GlaxoSmithKline's Lamictal.
Feb 26, 2026 14:51
Acerpure Eyes Emerging Markets After India Success
Acerpure plans to expand to Philippines, Vietnam, Thailand, and Indonesia after success in India. Focus on local manufacturing and investment.
Feb 26, 2026 14:49
Gushwork AI Raises Rs 81 Cr Funding
Gushwork AI secures Rs 81 cr funding led by Susquehanna Asia VC. Plans to invest in AI product development, talent & customer acquisition.
Feb 26, 2026 14:48
Cytiva Expands Bengaluru Fast Trak Facility
Cytiva expands its Fast Trak process development facility in Bengaluru to support biopharma companies in India and Asia-Pacific.
Feb 26, 2026 14:48
India Trade Policy Review at WTO in July 2026
India's 8th Trade Policy Review at WTO will take place in July 2026. Focus on digital customs reforms and TFA implementation.
Feb 26, 2026 14:33

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com